Home›Companies›Biotech & Pharma›Mantis Biotechnology

Mantis Biotechnology Corp

Updated Oct 27, 2026·Latest SEC filing Dec 3, 2025·Suggest an edit

About Mantis Biotechnology

Mantis Biotechnology is a private company based in San Francisco, California, incorporated in 2025 in Delaware. It has reported $4,824,999 raised in one offering on Form D since December 2025. Its chief executive is Georgia Witchel.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 17, 2025Dec 3, 2025$4,824,999of $5.5M target5$964KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Mantis Biotechnology's Form D filed Dec 3, 2025.

JL
Jessica Leao
Director
GW
Georgia Witchel
Chief Executive Officer and director

Sources

  1. SECMantis Biotechnology Corp filing history